BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis.
BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC). Here, we evaluated the prognostic value of BT3.2 at the protein level in specimen from 199 HG-EOC patients. As the on...
Main Authors: | Cécile Le Page, Alexandre Marineau, Patrick K Bonza, Kurosh Rahimi, Louis Cyr, Ingrid Labouba, Jason Madore, Nathalie Delvoye, Anne-Marie Mes-Masson, Diane M Provencher, Jean-François Cailhier |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3369854?pdf=render |
Similar Items
-
A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma
by: Cécile Le Page, et al.
Published: (2019-07-01) -
Predictive and Prognostic Protein Biomarkers in Epithelial Ovarian Cancer: Recommendation for Future Studies
by: Cécile Le Page, et al.
Published: (2010-05-01) -
A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis
by: Laudine Communal, et al.
Published: (2021-05-01) -
Ran GTPase: A Key Player in Tumor Progression and Metastasis
by: Zied Boudhraa, et al.
Published: (2020-05-01) -
RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer.
by: Katia Y Cáceres-Gorriti, et al.
Published: (2014-01-01)